These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19808354)

  • 1. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.
    Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL
    Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction.
    Shah KB; Kop WJ; Christenson RH; Diercks DB; Henderson S; Hanson K; Li SY; deFilippi CR
    Clin Chem; 2011 Jun; 57(6):874-82. PubMed ID: 21515743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.
    Januzzi JL; Peacock WF; Maisel AS; Chae CU; Jesse RL; Baggish AL; O'Donoghue M; Sakhuja R; Chen AA; van Kimmenade RR; Lewandrowski KB; Lloyd-Jones DM; Wu AH
    J Am Coll Cardiol; 2007 Aug; 50(7):607-13. PubMed ID: 17692745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
    Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A;
    J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.
    Manzano-Fernández S; Mueller T; Pascual-Figal D; Truong QA; Januzzi JL
    Am J Cardiol; 2011 Jan; 107(2):259-67. PubMed ID: 21211603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction.
    Weir RA; Miller AM; Murphy GE; Clements S; Steedman T; Connell JM; McInnes IB; Dargie HJ; McMurray JJ
    J Am Coll Cardiol; 2010 Jan; 55(3):243-50. PubMed ID: 20117403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural heart disease and ST2: cross-sectional and longitudinal associations with echocardiography.
    deFilippi C; Daniels LB; Bayes-Genis A
    Am J Cardiol; 2015 Apr; 115(7 Suppl):59B-63B. PubMed ID: 25702279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.
    Rehman SU; Mueller T; Januzzi JL
    J Am Coll Cardiol; 2008 Oct; 52(18):1458-65. PubMed ID: 19017513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.
    Kim MS; Jeong TD; Han SB; Min WK; Kim JJ
    J Korean Med Sci; 2015 May; 30(5):569-75. PubMed ID: 25931787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.
    Piper SE; Sherwood RA; Amin-Youssef GF; Shah AM; McDonagh TA
    Int J Cardiol; 2015 Jan; 178():284-91. PubMed ID: 25465308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure.
    Broch K; Andreassen AK; Ueland T; Michelsen AE; Stueflotten W; Aukrust P; Aakhus S; Gullestad L
    Int J Cardiol; 2015 Jan; 179():378-84. PubMed ID: 25464491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGAL and ST2 levels in ambulatory patients with chronic heart failure. Clinical and echocardiographic correlates.
    Ventoulis I; Mantziari L; Mouratoglou SA; Kamperidis V; Giannakoulas G; Ziakas A; Tsalikakis D; Giamouzis G; Hitoglou-Makedou A; Karvounis H
    Scand Cardiovasc J; 2015 Aug; 49(4):213-9. PubMed ID: 25919009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor-related protein ST2 and mitral valve repair outcome in patients with chronic degenerative mitral regurgitation.
    Galeone A; Lessana A; Mascolo E; Di Serio F; Marraudino N; Laborde F; Paparella D
    Thorac Cardiovasc Surg; 2014 Feb; 62(1):47-51. PubMed ID: 24065602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
    Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
    Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction.
    Fousteris E; Melidonis A; Panoutsopoulos G; Tzirogiannis K; Foussas S; Theodosis-Georgilas A; Tzerefos S; Matsagos S; Boutati E; Economopoulos T; Dimitriadis G; Raptis S
    Cardiovasc Diabetol; 2011 Nov; 10():101. PubMed ID: 22104207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department.
    Dieplinger B; Gegenhuber A; Kaar G; Poelz W; Haltmayer M; Mueller T
    Clin Biochem; 2010 Jun; 43(9):714-9. PubMed ID: 20153308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.
    Secemsky EA; Scherzer R; Nitta E; Wu AH; Lange DC; Deeks SG; Martin JN; Snider J; Ganz P; Hsue PY
    JACC Heart Fail; 2015 Aug; 3(8):591-9. PubMed ID: 26164679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble ST2 serum concentration and renal function in heart failure.
    Bayes-Genis A; Zamora E; de Antonio M; Galán A; Vila J; Urrutia A; Díez C; Coll R; Altimir S; Lupón J
    J Card Fail; 2013 Nov; 19(11):768-75. PubMed ID: 24263122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel.
    Januzzi JL; Mebazaa A; Di Somma S
    Am J Cardiol; 2015 Apr; 115(7 Suppl):26B-31B. PubMed ID: 25665762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.